MON-378 Efficacy and Safety of Romosozumab vs Alendronate Is Similar Across Different Levels of Renal Function Among Postmenopausal Women with Osteoporosis

Postmenopausal women with osteoporosis may also have renal insufficiency. We conducted a post hoc analysis of the ARCH study to determine the efficacy and safety of romosozumab (Romo) vs alendronate (ALN) among patients with different levels of baseline renal function. In ARCH, 4,093 postmenopausal...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Endocr Soc
Главные авторы: Miller, Paul, Cheung, Angela M, Reid, Ian, Rojeski, Maria, Vanderkelen, Mark, Yang, Wenjing, Santiago, Norma Ruiz, Oates, Mary
Формат: Artigo
Язык:Inglês
Опубликовано: Oxford University Press 2020
Предметы:
Bone and Mineral Metabolism
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7207955/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvaa046.050
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы